“Services. The Company will, following provision and approval of Know Your Customer documentation, provide the Merchant the Merchant Account and allow the Merchant to commence utilisation of the Services as are presently operational to process Transactions.”
“Merchant Account. (a) Merchant Account receipt of funds via a “Request Payment Users’ transaction” (“RPU transaction”) or through the dedicated SEPA IBAN. Through this process the Merchant shall have the ability to receive funds into its Merchant Account from Customers Transactions where their Customer does not hold an Account. (i) The Merchant may provide a payment reference number to their Customer and the Company will allow the Customer to instruct the Customer’s bank to transfer the funds identified by that payment reference number to the Company and the Company will transfer such funds directly to the Merchant’s Account. (ii) The Merchant may also utilise an API, as agreed between the Company and the Merchant, to initiate an incoming RPU transaction. (iii) The Merchant’s Customer does not have to hold an Account for the Merchant to receive payment by the RPU or SEPA transaction services, but is required to comply with the information requirements of EU Regulation 2015/847 and the Company’s AML Policy, and provide the necessary information and documents to accompany transfers of funds as required by the Company before the deadline specified by the Company’s representative.”
“(a) Relationship Between Parties. The Parties to this Agreement are independent contractors and nothing in this Agreement shall make them joint venturers, partners, employees, agents or other representatives of the other Party here.”
“In my viewCPR 31.18 merely preserves the Norwich Pharmacal jurisdiction -CPR 31.18 provides thatCPR 31.16 andCPR 31.17 in no way limit the court's pre-existing jurisdiction under Norwich Pharmacal . It in no way modifies the established principles governing the exercise of that jurisdiction. Those established principles require regard to be had to the existence of other means available for obtaining the information needed and accordingly require regard to be had toCPR 31.16 and 17 . It is entirely in accord withCPR 31.18 that, ifCPR 31.16 provides an alternative means of obtaining the information required by the Claimant, the Norwich Pharmacal jurisdiction should not be exercisable. The power to grant Norwich Pharmacal relief continues to subsist but in accordance with the established principles governing its exercise in cases where its exercise is no longer necessary, it no longer should be invoked.”